1650 Owens Street
105 articles with Gladstone Institutes
The biotech company MedaRed, Inc. is founded on groundbreaking basic research from Gladstone Institutes, UC San Francisco, and UC San Diego.
Keller’s work with pluripotent stem cells has led to a platform for disease modeling and regenerative medicine.
First sequence of the Komodo dragon genome reveals clues about its evolution.
Gladstone scientists reveal how gene mutations can alter small groups of cells and result in congenital heart disease.
Benoit Bruneau is selected to lead the Gladstone Institute of Cardiovascular Disease.
Here are some of the top research stories that happened around the industry this week.
The National Institutes of Health renews its funding of a promising internship program at the Gladstone Institutes.
Basic science discovery explains a fundamental way human cells differ from yeast cells.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Since the CRISPR genome editing technology was invented in 2012, it has shown great promise to treat a number of intractable diseases.
This annual prize supports the brightest scientists using cellular reprogramming for regenerative medicine
Robert Mahley, founder and president of Gladstone Institutes, an internationally-recognized expert on heart disease, cholesterol metabolism and Alzheimer’s disease, is launching a biotech company to focus on Alzheimer’s disease. The company is called GABAeron.
It has long been known that patients with Alzheimer’s disease have abnormalities in the vast network of blood vessels in the brain. Some of these alterations may also contribute to age-related cognitive decline in people without dementia. However, the ways in which such vascular pathologies contribute to cognitive dysfunction have largely remained a mystery. Until now, that is.
You can think of DNA as a string of letters—As, Cs, Ts, and Gs—that together spell out the information needed for the construction and function of cells.
New Year, fresh start? Could be. WalletHub recently compared more than 180 cities across the U.S., using 30 key indicators to evaluate their job strength. Some of those factors were job opportunities, employment growth, monthly average starting salary and employment outlook.
An unexpected brain region is important for Dravet Syndrome, finds study.
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes and UC San Francisco may finally change that.
Shipman will build new technologies to understand the development of the brain.
Gladstone scientists uncover new gatekeeper function of anti-aging molecule.
New Immunotherapy Targeting Blood-Clotting Protein Protects Multiple Sclerosis and Alzheimer’s Disease Models
Gladstone researchers have stopped the detrimental effects of blood-brain barrier leaks.